Journal of Pediatric and Adolescent Gynecology
Volume 20, Issue 1 , Pages 3-12 , February 2007

Premenstrual Syndrome and Premenstrual Dysphoric Disorder

  • Paula K. Braverman, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Paula K. Braverman, MD, 3333 Burnet Avenue, Mail Location 4000, Cincinnati, OH 45229

References 

  1. Mishell DR. Premenstrual disorders: Epidemiology and disease burden. Am J Managed Care. 2005;11(Suppl):S473
  2. Halbreich U. The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder-clinical procedures and research perspectives. Gynecol Endocrinol. 2004;19:320
  3. Mortola JF, Girton L, Yen SS. Depressive episodes in premenstrual syndrome. Am J Obstet Gynecol. 1989;161:1682
  4. Mortola JF, Girton L, Beck L, et al. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences. Obstet Gynecol. 1990;76:302
  5. Johnson SR. Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: A clinical primer for practitioners. Obstet Gynecol. 2004;104:845
  6. American College of Obstetrics and Gynecology: ACOG practice bulletin: premenstrual syndrome. Washington, DC: ACOG; April 2000;15
  7. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, 4th ed, DSM-IV-Text Revision. DSM-IV-TR, Washington, DC: American Psychiatric Association; 2000;
  8. Case AM, Reid RL. Menstrual cycle effects on common medical conditions. Compr Ther. 2001;27:65
  9. Ling FW. Recognizing and treating premenstrual dysphoric disorder in the obstetric, gynecologic, and primary care practices. J Clin Psychiatry. 2000;61(Suppl 12):9
  10. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility, 7th ed.. Philadelphia: Lippincott Williams & Wilkins; 2005;
  11. Steiner M, Pearlstein T, Cohen LS, et al. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: The role of SSRIs. J Womens Health. 2006;15:57
  12. Magos JA, Studd JW. A simple method for the diagnosis of premenstrual syndrome by use of a self-assessment disk. Am J Obstet Gynecol. 1988;158:1024
  13. Halbreich U, Endicott J, Schact S, et al. The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form. Acta Psychiatr Scand. 1982;65:46
  14. Reid R. Premenstrual syndrome. Current Probl Obstet Gynecol Fertil. 1985;8:1
  15. Thys-Jacobs S, Alvir JM, Fratarcangelo P. Comparative analysis of three PMS assessment instruments-the identification of premenstrual syndrome with core symptoms. Psycopharmacol Bull. 1995;31:389
  16. Endicott J, Harrison W: Daily Rating of Severity of Problem Form. New York, Department of Research Assessment and Training, New York State Psychiatric Institute, 1990
  17. Steiner M, Streiner DL, Steinberg S, et al. The measurement of premenstrual mood symptoms. J Affective Disord. 1999;53:269
  18. Freeman EW, DeRubeis RJ, Rickels K. Reliability and validity of a daily diary for premenstrual syndrome. Psychiatry Res. 1996;65:97
  19. Chakmakjian ZH. A critical assessment of therapy for the premenstrual tension syndrome. J Reprod Med. 1983;28:532
  20. Singh BB, Berman BM, Simpson RL, et al. Incidence of premenstrual syndrome and remedy usage: a national probability sample study. Altern Ther Health Med. 1998;4:75
  21. Grady-Weliky TA. Premenstrual dysphoric disorder. NEJM. 2003;348:433
  22. Cleckner-Smith CS, Doughty AS, Grossman JA. Premenstrual symptoms. Prevalence and severity in an adolescent sample. J Adolesc Health. 1998;22:403
  23. Fisher M, Trieller K, Napolitano B. Premenstrual syndrome in adolescents. J Adolesc Health Care. 1989;10:369
  24. Derman O, Kanbur NO, Tokur TE, et al. Premenstrual syndrome and associated symptoms in adolescent girls. Eur J Obstet Gynecol Reprod Biol. 2004;116:201
  25. Raja SN, Feehan M, Stanton WR, et al. Prevalence and correlates of the premenstrual syndrome in adolescence. J Am Acad Child Adolesc Psychiatry. 1992;31:783
  26. Moos RH. The development of the Menstrual Distress Questionnaire. Psychosom Med. 1968;30:853
  27. Shye D, Jaffe B. Prevalence and correlates of premenstrual symptoms: A study of Israeli girls. J Adolesc Health. 1991;12:217
  28. Wilson CA, Keye WR. A survey of adolescent dysmenorrhea and premenstrual symptom frequency. J Adolesc Health Care. 1989;10:317
  29. Widholm O, Kantero R-L. Menstrual patterns in adolescent girls according to chronological and gynecological ages. Acta Obstet Gynecol Scand. 1971;(Suppl 14):19
  30. Dean BB, Bornstein JE. A prospective assessment investigating the relationship between work productivity and impairment with premenstrual syndrome. JOEM. 2004;46:649
  31. Bornstein J, Chiou C-F, Dean B, et al. Estimating direct and indirect costs of premenstrual syndrome. JOEM. 2005;47:26
  32. Dalton K, Dalton ME, Guthrie K. Incidence of premenstrual syndrome in twins. BMJ. 1987;295:1027
  33. Van der Akker OB, Stein GS, Neil MC, et al. Genetic and environmental variation in 2 British twin samples. Acta Genet Med Gemellol. 1987;36:541
  34. Perkonigg A, Yonkers KA, Pfister H, et al. Risk factors for premenstrual dysphoric disorder in a community sample of young women: the role of traumatic events and posttraumatic stress disorder. J Clin Psychiatry. 2004;65:1314
  35. Mortola JF. Premenstrual syndrome-pathophysiologic considerations. N Engl J Med. 1998;338:256
  36. Steiner M, Pearlstein T. Premenstrual dysphoria and the serotonin system: Pathophysiology and treatment. J Clin Psychiatry. 2000;61(Suppl 12):17
  37. Freeman EW. Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder. CNS Drugs. 2004;18:453
  38. Schmidt PJ, Neiman LK, Grover GN, et al. Lack of effect of induced menses on symptoms in women with premenstrual syndrome. N Engl J Med. 1991;324:1174
  39. Schmidt PJ, Nieman LK, Danaceau MA, et al. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 1998;338:209
  40. Morse G. Positively reframing perceptions of the menstrual cycle among women with premenstrual syndrome. J Obstet Gynecol Neonatal Nursing. 1999;28:165
  41. Girman A, Lee R, Kigler B. An integrative medicine approach to premenstrual syndrome. Am J Obstet Gynecol. 2003;188:S56
  42. Pearlstein T, Steiner M. Non-antidepressant treatment of premenstrual syndrome. J Clin Psychiatry. 2000;61(Suppl):22
  43. Goodale IL, Domar AD, Benson H. Alleviation of premenstrual syndrome, symptoms with the relaxation response. Obstet Gynecol. 1990;75:649
  44. Van Zak DB. Biofeedback treatments for the premenstrual and premenstrual affective syndromes. Int J Psychosom. 1994;41:53
  45. Groer M, Ohnesorge C. Menstrual-cycle lengthening and reduction in premenstrual distress through guided imagery. J Holistic Nurs. 1993;11:286
  46. Sridevi K, Rao K, Rao K. Yoga practice and menstrual distress. J Indian Acad Applied Psychol. 1996;22:47
  47. Lam RW, Carter D, Mistri S, et al. A controlled study of light therapy in women with late luteal phase dysphoric disorder. Psychiatry Res. 1999;86:185
  48. Parry BL, Mahan AM, Mostofi N, et al. Light therapy of late luteal phase dysphoric disorder: An extended study. Am J Psychiatry. 1993;150:1417
  49. Hernandez-Reif M, Martinez A, Field T, et al. Premenstrual symptoms are relieved by massage therapy. J Psychosom Obstet Gynecol. 2000;21:9
  50. Oleson T, Flocco W. Randomized controlled study of premenstrual symptoms treated with ear, hand, and foot reflexology. Obstet Gynecol. 1993;82:906
  51. Morse CA, Dennerstein L, Farrell E, et al. A comparison of hormone therapy, coping skills training, and relaxation for the relief of premenstrual syndrome. J Behav Med. 1991;14:469
  52. Kirkby RJ. Changes in premenstrual symptoms and irrational thinking following cognitive-behavioral coping skills training. J Consult Clin Psychology. 1994;62:1026
  53. Christensen AP, Oei TP. The efficacy of cognitive behaviour therapy in treating premenstrual dysphoric changes. J Affective Disorders. 1995;33:57
  54. Blake F, Salkovskis P, Gath D, et al. Cognitive therapy for premenstrual syndrome: A controlled trial. J Psychosomatic Res. 1998;45:307
  55. Scully D, Kremer J, Meade MM, et al. Physical exercise and psychological well being: a critical review. Br J Sports Med. 1998;32:111
  56. Prior JC, Vigna Y, Sciarretta D, et al. Conditioning exercise decreases premenstrual symptoms: a prospective controlled 6-month trial. Fertil Steril. 1987;47:402
  57. Steege JF, Blumenthal JA. The effects of aerobic exercise on premenstrual symptoms in middle-aged women: a preliminary study. J Psychosom Res. 1993;37:127
  58. Rapkin AJ. New treatment approaches for premenstrual disorders. Am J Managed Care. 2005;11(Suppl):S480
  59. Stevinson C, Ernst E. Complementary/alternative therapies for premenstrual syndrome: A systematic review of randomized controlled trials. Am J Obstet Gynecol. 2001;185:227
  60. Thys-Jacobs S, Starky P, Bernstein D, et al. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. Am J Obstet Gynecol. 1998;179:444
  61. Bertone-Johnson ER, Hankinson SE, Bendich A, et al. Calcium and vitamin D intake and the risk of incident premenstrual syndrome. Arch Int Med. 2005;165:1246
  62. Facchinetti F, Borella P, Sauces G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991;78:177
  63. Walker AF, De Souza MC, Vickers MF, et al. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health. 1998;7:1157
  64. Khine K, Rosenstein DL, Elin RJ, et al. Magnesium (Mg) retention and mood effects after intravenous Mg infusion in premenstrual dysphoric disorder. Biol Psychiatry. 2006;59:327
  65. Wyatt KM, Dimmock PW, Jones PW, et al. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ. 1999;318:1375
  66. London RS, Murphy L, Kitowski KE, et al. Efficacy of alpha-tocopherol in the treatment of premenstrual syndrome. J Reprod Med. 1987;32:400
  67. Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Human Psychopharmacol Clin Exp. 2003;18:191
  68. Berger D, Schaffner W, Schrader E, et al. Efficacy of Vitex agnus castus L.extract Ze 440 in patients with pre-menstrual syndrome (PMS). Arch Gynecol Obstet. 2000;264:150
  69. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomized, placebo controlled study. BMJ. 2001;322:134
  70. Stevinson C, Ernst E. A pilot study of hypericum perforatum for the treatment of premenstrual syndrome. BJOG. 2000;107:870
  71. Sayegh R, Schiff I, Wurtman J, et al. The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome. Obstet Gynecol. 1995;86:520
  72. Joffe H, Cohen LS, Harlow BL. Impact of oral contraceptive pill use on premenstrual mood: Predictors of improvement and deterioration. Am J Obstet Gynecol. 2003;189:1523
  73. Apter D, Boros A, Baumgartner W, et al. Effect of an oral contraceptive containing droperionone and ethinyl estradiol on general well-being and fluid-related symptoms. Eur J Contracept Reprod Health Care. 2003;8:37
  74. Freeman EW, Kroll R, Rapkin A, et al. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J Womens Health Gend Based Med. 2001;10:561
  75. Yonkers KA, Brown C, Pearlstein TB, et al. Efficacy of a new low-dose oral contraceptive with drosperinone in premenstrual dysphoric disorder. Obstet Gynecol. 2005;106:492
  76. Emans SJ, Laufer MR, Goldstein DP. Pediatric and Adolescent Gynecology, 5th ed.. Philadelphia: Lippincott Williams & Wilkins; 2005;
  77. Sillem M, Schneidereit R, Heithecker R, et al. Use of an oral contraceptive containing drosperionone in an extended regimen. Eur J Contracept Reprod Health Care. 2003;8:162
  78. Freeman EW, Sondheimer SJ, Rickels K. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. Psychopharmacol Bull. 1997;33:303
  79. Wang M, Hammarback S, Lindhe BA, et al. Treatment of premenstrual syndrome by spironolactone: a double-blind placebo controlled study. Acta Obstet Gynecol Scand. 1995;74:803
  80. Dimmock PW, Wyatt KM, Jones PW, et al. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet. 2000;356:1131
  81. Wyatt KM, Dimmock PW, O'Brien PM: Selective serotonin reuptake inhibitors for premenstrual syndrome. The Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No: CD001396.DOI:10.1002/14651858.CD001396
  82. Freeman EW, Rickels K, Sondheimer SJ, et al. Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder. Am J Psychiatry. 2004;161:343
  83. Freeman EW, Sondheimer SJ, Sammel MD, et al. A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder. J Clin Psychiatry. 2005;66:789
  84. Steiner M, Steinberg S, Stewart D, et al. Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med. 1995;332:1529
  85. Freeman EW, Rickels K, Yonkers KA, et al. Venlafaxine in the treatment of premenstrual dysphoric disorder. Obstet Gynecol. 2001;98:737
  86. Cohen LS, Soares CN, Lyster A, et al. Efficacy and tolerability of premenstrual use of venlafaxine (flexible dose) in the treatment of premenstrual dysphoric disorder. J Clin Psychopharmacol. 2004;24:540
  87. Silber TJ, Valadez-Meltzer A. Premenstrual dysphoric disorder in adolescents: case reports of treatment with fluoxetine and review of the literature. J Adolesc Health. 2005;37:518
  88. Freeman EW, Rickels K, Sondheimer SJ, et al. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA. 1995;274:51
  89. Smith S, Rinehart JS, Ruddock VE, et al. Treatment of premenstrual syndrome with alprozolam: Results of a double-blind, placebo-controlled, randomized crossover clinical trial. Obstet Gynecol. 1987;70:37
  90. Harrison WM, Endicott J, Nee J. Treatment of premenstrual dysphoria with alprazolam. A controlled study. Arch Gen Psychiatry. 1990;47:270
  91. Landen M, Eriksson O, Sundblad C, et al. Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of busprione, nefazodone and placebo. Psychopharmacology. 2001;155:292

PII: S1083-3188(06)00293-2

doi: 10.1016/j.jpag.2006.10.007

Journal of Pediatric and Adolescent Gynecology
Volume 20, Issue 1 , Pages 3-12 , February 2007

Article Tools